Susquehanna Fundamental Investments LLC Takes $1.99 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Susquehanna Fundamental Investments LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,200 shares of the company’s stock, valued at approximately $1,992,000.

Other institutional investors also recently modified their holdings of the company. CreativeOne Wealth LLC bought a new position in shares of HCA Healthcare in the first quarter worth approximately $231,000. New Mexico Educational Retirement Board boosted its stake in HCA Healthcare by 29.9% in the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares in the last quarter. Kingswood Wealth Advisors LLC purchased a new stake in HCA Healthcare in the first quarter worth approximately $566,000. Teachers Retirement System of The State of Kentucky boosted its stake in HCA Healthcare by 15.6% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after buying an additional 26,919 shares in the last quarter. Finally, Brave Warrior Advisors LLC boosted its stake in HCA Healthcare by 182.1% in the fourth quarter. Brave Warrior Advisors LLC now owns 3,873 shares of the company’s stock worth $1,048,000 after buying an additional 2,500 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Up 0.8 %

HCA Healthcare stock opened at $406.43 on Tuesday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $409.42. The stock has a market capitalization of $106.45 billion, a PE ratio of 20.26, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The business’s fifty day moving average is $380.53 and its 200 day moving average is $343.58.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period last year, the firm posted $4.29 earnings per share. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Activity

In related news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HCA. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Wells Fargo & Company upped their target price on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Leerink Partners upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. UBS Group upped their target price on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Finally, Royal Bank of Canada upped their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.